Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Timing is everything: Clinical evidence supports pre-symptomatic treatment for spinal muscular atrophy
Anna A. L. Motyl, Thomas H. Gillingwater
Cell Reports Medicine (2022) Vol. 3, Iss. 8, pp. 100725-100725
Open Access | Times Cited: 17

Showing 17 citing articles:

Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’
Angela Lek, Evrim Atas, Sharon Hesterlee, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 3, pp. 327-336
Open Access | Times Cited: 28
Spinal Muscular Atrophy Update in Best Practices
Mary Schroth, J. Deans, Kapil Arya, et al.
Neurology Clinical Practice (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 12
Report on the 6th Ottawa International Conference on Neuromuscular Disease & Biology – September 7–9, 2023, Ottawa, Canada
Jodi Warman‐Chardon, Bernard J. Jasmin, Rashmi Kothary, et al.
Journal of Neuromuscular Diseases (2025) Vol. 12, Iss. 1
Closed Access
Assessment of social emotional, cognitive and communicative development and adaptive behavior in children with spinal muscular atrophy 5q
Yu. О. Papina, Н. Н. Заваденко, Е. А. Melnik, et al.
Neuromuscular Diseases (2025) Vol. 15, Iss. 1, pp. 39-52
Open Access
The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review
Akos Herzeg, Beltran Borges, Loukas N. Diafos, et al.
Prenatal Diagnosis (2024)
Open Access | Times Cited: 3
Neonatal screening for spinal muscular atrophy: A pilot study in Brazil
Alice Brinckmann Oliveira Netto, Ana Carolina Brusius‐Facchin, Júlia F. Lemos, et al.
Genetics and Molecular Biology (2023) Vol. 46, Iss. 3 suppl 1
Open Access | Times Cited: 8
Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey
Mary Ann Curry, Rosángel Cruz, Lisa Belter, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 583-598
Open Access | Times Cited: 1
Long-Term Follow-Up Cares and Check Initiative: A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn Screening
Mei Lietsch, Kee Chan, Jennifer Taylor, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 2, pp. 34-34
Open Access | Times Cited: 1
Adeno-associated virus vector-based gene therapy for hereditary diseases: current problems of application and approaches to solve them
Tatiana V. Egorova, Aleksandr Piskunov, Dmitry Poteryaev
Biological Products Prevention Diagnosis Treatment (2024) Vol. 24, Iss. 2, pp. 123-139
Open Access | Times Cited: 1
Timing of SMN replacement therapies in mouse models of spinal muscular atrophy: a systematic review and meta-analysis
Helena Chaytow, Anna A. L. Motyl, Yu-Ting Huang, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 1
Our Journey from Individual Efforts to Nationwide Support: Implementing Newborn Screening for Spinal Muscular Atrophy in Serbia
Miloš Brkušanin, Nemanja Garai, J Karanović, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 57-57
Open Access | Times Cited: 1
Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights
Mary Ann Curry, Ilse Peterson, Lisa Belter, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 5, pp. 1631-1647
Open Access | Times Cited: 1
Clinical and Genetic Profiles of 5q- and Non-5q-Spinal Muscular Atrophy Diseases in Pediatric Patients
Hisahide Nishio, Emma Tabe Eko Niba, Toshio Saito, et al.
Genes (2024) Vol. 15, Iss. 10, pp. 1294-1294
Open Access
SMN2 Copy Number Association with Spinal Muscular Atrophy Severity: Insights from Colombian Patients
José Lamadrid-González, Sandra Milena Castellar-Leones, Julio Contreras-Velásquez, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6402-6402
Open Access
Developing medicines for the pre-symptomatic stage of degenerative neurological conditions: Challenges and opportunities
Liz Meszaros, Lorenzo Guizzaro
Revue Neurologique (2023) Vol. 180, Iss. 3, pp. 141-146
Open Access
AAV-Vektoren – die imposante Karriere eines Parvovirus
Nico Martin Jäschke, Hildegard Büning
Springer eBooks (2023), pp. 51-71
Closed Access
New results for risdiplam in spinal muscular atrophy
Susan T. Iannaccone
The Lancet Neurology (2022) Vol. 21, Iss. 12, pp. 1065-1066
Closed Access
Page 1

Scroll to top